# Rohto Pharmaceutical Co.,Ltd. (RPHCF)

> 防御性消费 · JP · 以 JPY 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/RPHCF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2027 | ¥ 90.96B | ¥ 10.57B | N/A | ¥ 57.68B | ¥ 307.25B |
| 2026 | ¥ 345.95B | ¥ 34.44B | N/A | ¥ 60.62B | ¥ 303.73B |
| 2025 | ¥ 305.70B | ¥ 30.80B | N/A | ¥ 50.22B | ¥ 260.09B |
| 2024 | ¥ 270.84B | ¥ 30.94B | ¥ 0 | ¥ 10.49B | ¥ 246.32B |
| 2023 | ¥ 238.10B | ¥ 26.37B | ¥ 0 | ¥ 11.69B | ¥ 1.58B |
| 2022 | ¥ 199.65B | ¥ 21.04B | N/A | ¥ 21.38B | ¥ 1.46B |
| 2021 | ¥ 181.05B | ¥ 16.74B | N/A | ¥ 8.10B | ¥ 1.41B |
| 2020 | ¥ 187.06B | ¥ 15.30B | N/A | ¥ 7.30B | ¥ 139.28B |
| 2019 | ¥ 180.21B | ¥ 9.61B | N/A | ¥ 5.17B | ¥ 131.27B |
| 2018 | ¥ 169.91B | ¥ 9.19B | N/A | ¥ 5.85B | ¥ 127.68B |
| 2017 | ¥ 153.37B | ¥ 9.93B | N/A | ¥ 5.12B | ¥ 118.00B |
| 2016 | ¥ 166.83B | ¥ 9.12B | N/A | ¥ 5.45B | ¥ 110.81B |
| 2015 | ¥ 152.78B | ¥ 8.68B | N/A | ¥ 9.42B | ¥ 110.09B |
| 2014 | ¥ 145.12B | ¥ 9.01B | N/A | ¥ 9.88B | ¥ 98.25B |
| 2013 | ¥ 132.72B | ¥ 8.34B | N/A | ¥ 7.19B | ¥ 93.45B |
| 2012 | ¥ 126.19B | ¥ 8.58B | N/A | ¥ 8.44B | ¥ 83.35B |
| 2011 | ¥ 120.53B | ¥ 8.33B | ¥ 4.33B | ¥ 5.92B | ¥ 77.67B |
| 2010 | ¥ 118.36B | ¥ 8.10B | ¥ 10.73B | ¥ 8.15B | ¥ 73.62B |
| 2009 | ¥ 91.25B | ¥ 5.27B | ¥ 4.30B | ¥ 8.93B | ¥ 67.07B |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.19 |
| 总负债 / 股东权益 | 0.51 |
| 流动比率 | 2.17 |

## 债务覆盖

| 指标 | 数值 |
| --- | --- |
| 总债务 / 盈利 | 2.70 |
| 总债务 / 自由现金流 | 9.87 |

## 其他视图

- [指标](https://sponda.capital/zh/RPHCF.md)
- [图表](https://sponda.capital/zh/RPHCF/charts.md)
- [对比](https://sponda.capital/zh/RPHCF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。